H1015
25-羟基胆甾醇
≥98%
别名:
5-胆甾烯-3β,25-二醇
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C27H46O2
化学文摘社编号:
分子量:
402.65
NACRES:
NA.77
PubChem Substance ID:
eCl@ss:
39023139
UNSPSC Code:
41141804
MDL number:
Beilstein/REAXYS Number:
3161259
biological source
synthetic (organic)
Quality Level
assay
≥98%
form
powder
shipped in
ambient
storage temp.
room temp
SMILES string
[H][C@@]12[C@]([C@](CC[C@H](O)C3)(C)C3=CC2)([H])CC[C@@]4(C)[C@@]1([H])CC[C@]4([H])[C@]([H])(C)CCCC(C)(O)C
InChI
1S/C27H46O2/c1-18(7-6-14-25(2,3)29)22-10-11-23-21-9-8-19-17-20(28)12-15-26(19,4)24(21)13-16-27(22,23)5/h8,18,20-24,28-29H,6-7,9-17H2,1-5H3/t18-,20+,21+,22-,23+,24+,26+,27-/m1/s1
InChI key
INBGSXNNRGWLJU-ZHHJOTBYSA-N
Application
25-羟基胆固醇用于治疗小鼠神经母细胞瘤细胞，以激活 ABCA1 信号，并用于与脂肪酸代谢相关的研究。
Biochem/physiol Actions
25-羟基胆固醇是一种侧链氧甾醇，据报道可引发许多胆固醇分子的活化。这引发了它们从细胞膜到内质网（ER）的运动。25-羟基胆固醇影响免疫系统，并在动脉粥样硬化的发病机制中起关键作用。
抑制甾醇调节元件结合蛋白（SREBPs）的裂解。 25-羟基胆固醇通过下调 Bcl-2 表达和激活半胱天冬酶，从而诱导细胞凋亡。
Preparation Note
可以在乙醇中制备 25-羟基胆固醇的储备溶液，并将其溶解在细胞培养基中，使最终浓度为1mg/ml。
Still not finding the right product?
Explore all of our products under 25-羟基胆甾醇
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
商品
肝脏中胆固醇的合成量由饮食中的胆固醇水平来严格调节。LDL受体调节富含脂质的低密度脂蛋白（LDL）颗粒的细胞转运。
Cholesterol synthesis regulation by dietary levels, LDL receptors control lipid-rich LDL particle transport in cells.
25-hydroxycholesterol enhances cytokine release and toll-like receptor 3 response in airway epithelial cells
Koarai A et al
Respiratory Research, 13, doi: 10-doi: 10 (2012)
Brett N Olsen et al.
Biophysical journal, 100(4), 948-956 (2011-02-16)
Side-chain oxysterols are enzymatically generated oxidation products of cholesterol that serve a central role in mediating cholesterol homeostasis. Recent work has shown that side-chain oxysterols, such as 25-hydroxycholesterol (25-HC), alter membrane structure in very different ways from cholesterol, suggesting a
Joseph Longo et al.
Molecular metabolism, 25, 119-130 (2019-04-27)
The statin family of cholesterol-lowering drugs has been shown to induce tumor-specific apoptosis by inhibiting the rate-limiting enzyme of the mevalonate (MVA) pathway, HMG-CoA reductase (HMGCR). Accumulating evidence suggests that statin use may delay prostate cancer (PCa) progression in a
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| H1015-10MG | 04061833663769 |
| H1015-100MG | 04061833076415 |
| H1015-25MG | 04061833663776 |